MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York policy

S9221: Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program

NY Senate · Sponsor Christopher Ryan

Jurisdiction
New York State
Applies to
New York State (proposed)
Effective
June 4, 2026

What it requires

Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.

ny-statesenatelegislationbill

Official source ↗

Free account

Create a free account

Track New York policy and save searches across the Network. Free. No card required.

Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →